Virtual Rehab is pleased to announce that Dr. Larry Wray joins as a member of the Advisory Board.
Dr. Wray has over 30 years of experience in healthcare. He is currently consulting early stage and established companies, universities and non-profit organizations on commercializing new technologies as clinical diagnostic products or research tools.
Prior to his current practice, Dr. Wray most recently was VP, Development at Nanomix, a nanotechnology based point of care diagnostic company and immediately prior to that was VP, R&D for the diagnostics business at PerkinElmer, where he was responsible for a global organization with sites in the U.S., China, and Europe. He has also held leadership positions in R&D, program management, business development, and manufacturing at BayPoint Biosystems (an oncology diagnostic company), Celera (a molecular diagnostic company, now part of Quest), Ventana (a tissue diagnostics company, now part of Roche) and Abbott Diagnostics.
Virtual Rehab looks forward to working closely with Dr. Wray.